Navigation Links
URAC Rolls Out Revised Standards to Protect Personal Health Information and Boost Consumer Privacy on the Web
Date:10/30/2008

WASHINGTON, Oct. 30 /PRNewswire-USNewswire/ -- Today URAC announced the rollout of significant revisions to its health information technology standards. The changes affect Health Web Site accreditation and URAC's HIPAA Privacy and Security Standards.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030501/URACLOGO)

URAC, an independent, non-profit accreditation organization, revised the HIPAA Privacy and Security standards to emphasize the need for annual workforce training. The revised standards clarify notice of privacy practices to consumers, including notice of material changes in privacy practices. Accredited organizations are now required to conduct a risk assessment. The risk assessment must include an analysis of the use of portable media such as USB drives and lap top computers -- a need generated by an evolving technology landscape and highlighted by HIPAA security regulators.

URAC pioneered Health Web Site accreditation in 2001 to assess the quality and privacy practices of URAC-accredited sites. Rapid changes and innovation in health care raise a number of pivotal challenges for organizations providing health information to consumers via the Internet. In response to this challenge, URAC has enhanced editorial transparency, requiring health Web site providers to verify and disclose the credentials of its health content reviewers and how it conducts credentials verification. This transparency is important to consumers who need to wisely evaluate the quality of the information they are using.

"As consumers now rely on the Web as their primary source of health information, URAC's Health Web Site Accreditation provides them with the confidence that the quality and credibility of the health information is transparent, with clear privacy practices and ethical standards," said John M. Hopkins, vice president of best practices for WebMD. "In keeping wi
'/>"/>

SOURCE URAC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Say goodbye to back fat rolls
2. Together Rx Access(R) Program Enrolls More Than 1.5 Million Americans Without Prescription Drug Coverage
3. Miami Rolls Out the Red Carpet for Latin Star Studded FedEx/St. Jude Gala
4. ELLE Eco-Salon & Spa Rolls Thru Southern California Offering Styling, Mini- Makeovers and Beauty Treatments
5. GeneGo Rolls out MetaMiner Cystic Fibrosis - the First Disease-Specific Software Platform to Advance Drug Discovery
6. Tasker Products Rolls Out Scalder Application at Two New Poultry Processors Facilities
7. BET Rolls Out a Weekend of Award-Winning, HIV-Themed Programming Commemorating World AIDS Day
8. Siemens Rolls Out Its First Mobile Digital Mammography System in the U.S.
9. Psoriasis Cure Now Rolls Out First National Short Sleeve Day Saturday
10. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
11. URAC Releases Revised Standards For Nine Health Care Management Accreditation Programs
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Winter Spare the Air Alert in Effect for Thursday November 26 2009 62162 1Winter Spare the Air Alert in Effect for Thursday November 26 2009 62162 2Heska Announces Supply Agreement With Roche Diagnostics 6549 1Heska Announces Supply Agreement With Roche Diagnostics 6549 2Heska Announces Supply Agreement With Roche Diagnostics 6549 3Engineers doctors at UCLA develop novel material that could help fight arterial disease 62158 1Engineers doctors at UCLA develop novel material that could help fight arterial disease 62158 2Engineers doctors at UCLA develop novel material that could help fight arterial disease 62158 3Engineers doctors at UCLA develop novel material that could help fight arterial disease 62158 4